|本期目录/Table of Contents|

[1]包佳婷,王勇强,王 兵,等.2014-2017年我院鲍曼不动杆菌分布及ICU内鲍曼不动杆菌耐药性分析[J].天津医科大学学报,2019,25(06):600-604.
 BAO Jia-ting,WANG Yong-qiang,WANG Bing,et al.Analysis on the distribution of Acinetobacter baumannii in our hospital and the drug resistance of Acinetobacter baumannii in ICU from 2014 to 2017[J].Journal of Tianjin Medical University,2019,25(06):600-604.
点击复制

2014-2017年我院鲍曼不动杆菌分布及ICU内鲍曼不动杆菌耐药性分析(PDF)
分享到:

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:
25
期数:
2019年06期
页码:
600-604
栏目:
临床医学
出版日期:
2019-11-20

文章信息/Info

Title:
Analysis on the distribution of Acinetobacter baumannii in our hospital and the drug resistance of Acinetobacter baumannii in ICU from 2014 to 2017
文章编号:
1006-8147(2019)06-0600-05
作者:
包佳婷12王勇强2王 兵2许 华2高红梅2
(1.天津医科大学一中心临床学院重症医学科,天津300192;2.天津市第一中心医院重症医学科,天津 300192)
Author(s):
BAO Jia-ting12 WANG Yong-qiang2 WANG Bing2 XUN Hua2 GAO Hong-mei2
(1.Department of Critical Care Medicine, The First Center Clinical College , Tianjin Medical University, Tianjin 300192, China; 2.Department of Critical Care Medicine, Tianjin First Center Hospital, Tianjin Institute of Emergency Medicine, Tianjin 300192,China)
关键词:
鲍曼不动杆菌分布ICU耐药率变迁
Keywords:
Acinetobacter baumanniidistributionICUantimicrobial resistance
分类号:
R446
DOI:
-
文献标志码:
A
摘要:
目的:了解我院鲍曼不动杆菌临床分布情况及ICU内鲍曼不动杆菌的耐药性变迁,为临床指导用药、合理使用抗生素、预防耐药菌产生提供依据。方法:回顾性分析2014至2017年我院鲍曼不动杆菌分布及耐药情况,细菌药敏试验采用VITEK仪器法。结果:我院2014至2017年共分离出鲍曼不动杆菌2 246株,各年度分别检出数量为:413株(2014年)、565株(2015年)、644株(2016年)和624株(2017年)。标本类型主要为痰,占88%,其次为胆汁及腹腔引流液,占5.7%,除此之外,血液、伤口分泌物、胸水及脑脊液等也分离出鲍曼不动杆菌。鲍曼不动杆菌在我院各科室分布广泛,其中,综合ICU检出比最高,占20%,其次为呼吸内科,占9.3%,其余临床科室也均有分布。我院ICU病房内鲍曼不动杆菌对多种抗菌药物均表现较高的耐药性,其中,左氧氟沙星耐药率最低,为23.16%,且呈现逐年降低趋势,差异具有统计学意义(P<0.05)。其次是阿米卡星,其耐药率为27.62%。头孢哌酮舒巴坦耐药率变化较大,2014~2016年呈逐年上升,但2017年较2016年明显下降,且差异具有统计学意义(P<0.05)。其他抗生素耐药率均在80%以上,近几年来变化不大。结论:鲍曼不动杆菌可造成多部位的感染,且临床科室分布广泛,并对临床多种常用抗生素均具有较高的耐药性。
Abstract:
Objective: To investigate the distribution of the Acinetobacter baumannii in our hospital and the change of antimicrobial resistance in ICU,and provide some rationalization proposal on clinical medication, antibiotics use and prevention of resistant bacteria.Methods:Retrospective analysis of the distribution and resistance of Ab in our hospital during 2014-2017 was made in this study .The VITEK instrument method was adopted in the bacterial susceptibility test. Results: Totally, 2 246 strains of Acinetobacter baumannii were isolated from our hospital, including 413 strains (2014 year), 565 strains (2015 year), 644 strains (2016 year), and624 strains(2017 year). These bacteria were mainly derived from sputum samples, accounting for 88%. Bile and fluid of the peritoneal cavity accounted for 5.7%.In addition, the bacteria also was isolated from blood,wound secretions,pleuraleffusion and celebrospinal fluid. Ab is widely distributed in various departments of our hospital,of which thehighest is ICU accounting for 20%.The second is respiratory department about 9.3% and the other clinical departments also have the bacteria. Ab in the ICU of our hospital showed high resistance to various antibacterial drugs. Among them,the resistance to levofloxacin was the lowest(23.16%) and showed a decreasing trend year by year, andthe difference was statistically significant(P<0.05) .The second was amikacin with the resistance rate of 27.62%.The drug resistance rate of cefoperazone-sulbactam changed greatly and increased year by year during 2014-2016, but declined noticeably in 2017 compared with 2016(P<0.05).Other antibiotic resistance rates are all above 80%, and have no obvious change in recent years. Conclusion: Ab can cause multiple site infection and are widely distributed in clinical departments and has high resistance rate to various commonly used antibiotics.

参考文献/References:

[1] 张辉,张小江,徐英春,等. 2012年中国CHINET不动杆菌属细菌耐药性监测[J]. 中国感染与化疗杂志,2014,14(5):392
[2] 习慧明,徐英春,朱德妹,等. 2010年中国CHINET鲍曼不动杆菌耐药性监测[J]. 中国感染与化疗杂志,2012,12(2):98
[3] 王玲巧,毛翠,张学锋,等. 鲍曼不动杆菌对氨基糖苷类药物的耐药机制研究[J]. 检验医学与临床,2010,7(7):584
[4] Kempf M,Rolain J. Emergence of resistance to carbapenems in Acinetobacter baumannii in Europe: clinical impact and therapeutic options[J]. Int J Antimicrob Agents,2012, 39(2):105
[5] 张驰,杨羚,凌保东. 鲍曼不动杆菌8种RND外排泵介导替加环素耐药表型的研究[J]. 中国抗生素杂志,2018,43(2):115
[6] Lin M,Lin Y,Tu C,et al. Distribution of different efflux pump genes in clinical isolates of multidrug-resistant Acinetobacter baumannii and their correlation with antimicrobial resistance[J]. J Microbiol Immunol Infect,2017,50(2):224
[7] Rodríguez C H,Nastro M,Famiglietti A. Carbapenemases in Acinetobacter baumannii review of their dissemination in Latin America[J]. Rev Argent Microbiol,2018, 50(3):327
[8] 刘彦伶,毛静,贾蓓. 鲍曼不动杆菌耐药及治疗进展[J]. 国外医药(抗生素分册),2015, 36(2):63
[9] 罗鹏,戴玮,张莉萍. 1582株鲍曼不动杆菌的临床分布及耐药性分析[J]. 重庆医学,2011, 40(3):224
[10] 孙红爽,乜春城,陈赫军. 2012~2013年某院鲍曼不动杆菌的临床分布及耐药性分析[J]. 安徽医药,2015,19(1):189
[11] 徐桂婷,糜琛蓉,李文慧,等. 2008年~2012年住院患者鲍曼不动杆菌分布状况及耐药性分析[J]. 华西医学,2014,29(3):413
[12] 徐一鸣,王蓓,蒋晓飞. 2008至2012年鲍曼不动杆菌临床感染分布及耐药特征分析[J]. 检验医学,2014, 29(3):245
[13] Kang J,Gopala L,Reddy Tangadanchu V K,et al. Novel naphthalimide nitroimidazoles as multitargeting antibacterial agents against resistantAcinetobacter baumannii[J]. Future Med Chem,2018,10(7):711
[14] Soltani B,Heidari H,Ebrahim-Saraie H S,et al. Molecular characteristics of multiple and extensive drug-resistant Acinetobacter baumannii isolates obtained from hospitalized patients in Southwestern Iran[J]. Infez Med,2018,26(1):67
[15] Shukla M,Soni I,Matsuyama K,et al. Identification and bio-evaluation of SRI-12742 as a antimicrobial agent against multi-drug resistant Acinetobacter baumannii[J]. Int J Antimicrob Agents, 2018, 52(1):22
[16] 马玲,袁喆. 2006~2009年鲍曼不动杆菌感染分布特征及耐药性变迁[J]. 重庆医科大学学报,2010,35(8):1278
[17] 肖淑珍,徐桂婷,方洁,等. 鲍曼不动杆菌耐药性与抗菌药物使用情况的相关性分析[J]. 中国感染与化疗杂志,2013,13(6):446
[18] Fiester S E,Arivett B A,Beckett A C,et al. Miltefosine reduces the cytolytic activity and virulence of Acinetobacter baumannii[J]. Antimicrob Agents Chemother,2018, 63(1):e01409
[19] Wang T H,Leu Y S,Wang N Y,et al. Prevalence of different carbapenemase genes among carbapenem-resistant Acinetobacter baumannii blood isolates in Taiwan[J]. Antimicrob Resist Infect Control,2018,7:123
[20] Rui Y,Lu W,Li S,et al. Detection of common mobile genetic elements and genotyping of multidrug-resistant Gram-negative bacilli in blood specimens from septicemia patients in southern China[J]. Infect Drug Resist,2018,11:1741
[21] Kazmierczak K M,Tsuji M,Wise M G,et al. In vitro activity of cefiderocol,a siderophore cephalosporin,against a recent collection of clinically relevant carbapenem-nonsusceptible gram-negative bacilli,including serine carbapenemase- and metallo-beta-lactamase-producing isolates (SIDERO-WT-2014 Study)[J]. Int J Antimicrob Agents,2019, 53(2):177
[22] 潘慧. 鲍曼不动杆菌临床分布特征及耐药性分析[D]. 吉林大学,2015
[23] 王风娟,吕媛,李耘. 替加环素联合5种抗菌药物对多重耐药鲍曼不动杆菌的体外活性[J]. 中国临床药理学杂志,2013,29(5):345
[24] 晏奎,温汉春,陈一强,等. 磷霉素联合左氧氟沙星对鲍曼不动杆菌生物膜的体外研究[J]. 中国临床药理学杂志,2015, 31(4):276
[25] 张雪云,褚云卓,陈佰义. 多黏菌素B与利福平对亚胺培南耐药鲍曼不动杆菌联合药物敏感性研究[J]. 中华检验医学杂志,2006,(4):370
[26] 戴春梅,郑兰香,陈辉. 129株鲍曼不动杆菌所致医院感染的耐药性分析[J]. 实用预防医学,2006,(1):62
[27] 刘欣,徐娟,洪纯,等. 丁香酚和大蒜素分别与亚胺培南联用对多耐药鲍曼不动杆菌的体外抑菌实验研究[J]. 抗感染药学,2017, 14(1):17
[28] Gao W,Gopala L,Bheemanaboina RRY,et al. Discovery of 2-aminothiazolyl berberine derivatives as effectively antibacterial agents toward clinically drug-resistant Gram-negative Acinetobacter baumannii[J]. Eur J Med Chem,2018,146:15
[29] 史鹏伟,高艳彬,卢志阳,等. 抗菌肽LL-37对鲍曼不动杆菌生物膜的抑制作用[J]. 南方医科大学学报,2014, 34(3):426

相似文献/References:

[1]文晓龙,权 伟,江荣才.神经外科重症监护室中脑外伤感染泛耐药鲍曼不动杆菌12例分析[J].天津医科大学学报,2015,21(03):255.
[2]余 倩,胡志东,李 静,等.3种方法评估肺炎克雷伯菌及鲍曼不动杆菌对替加环素的体外药敏结果分析[J].天津医科大学学报,2015,21(06):510.
 YU Qian,HU Zhi-dong,LI Jing,et al.Effect of Tigecycline on Klebsiella pneumoniae and Acinetobacter baumanaii by susecptibility testing in vitro[J].Journal of Tianjin Medical University,2015,21(06):510.
[3]张 燕,何新飙.ICU患者感染鲍曼不动杆菌的危险因素及耐药性分析[J].天津医科大学学报,2016,22(04):318.
 ZHANG Yan,HE Xin-biao.Analysis of risk factors and drug resistance of the patients fected with Acinetobater baumanii in intensive care unit[J].Journal of Tianjin Medical University,2016,22(06):318.
[4]翟慧群,班 博.鲍曼不动杆菌感染对气管插管患者预后的影响[J].天津医科大学学报,2016,22(04):335.

备注/Memo

备注/Memo:
基金项目 天津市卫生和计划生育委员会攻关课题(项目编号:16KG106)
作者简介 包佳婷(1991-),女,硕士在读, 研究方向:急诊医学; 通信作者: 高红梅,E-mail :ghm 182@163.com 。
更新日期/Last Update: 2020-01-20